Sara Bonstein has served as a member of our board of directors since April 2026 and is chairperson of the board’s audit committee. Ms. Bonstein currently serves as chief financial officer of Insmed, Inc. where she oversees key financial functions including capital raising, investor relations, accounting, treasury, financial planning and analysis and procurement. With more than two decades of operational and financial leadership in the life sciences industry, Ms. Bonstein has deep experience in raising capital and has raised more than $4 billion while establishing strong financial controls, streamlining business operations, and building high-performing teams. Prior to joining Insmed, Ms. Bonstein served as the chief financial officer and chief operating officer at OncoSec Medical and as the chief financial officer at Advaxis, Inc. She also previously held positions of increasing responsibility at Eli Lilly & Company and Johnson & Johnson. She is the chair of the board of directors of Xilio Therapeutics, Inc. She holds a B.S. in finance from The College of New Jersey and an M.B.A. from Rider University.